Advertisement
Advertisement
ESTA
Establishment Labs Holdings Inc.
71.77
USDSponsored
-0.26
-0.36%
May 08, 16:00 UTC -4
Closed
After-Market
71.77
0.00
0.00%
ESTA Earnings Reports
Positive Surprise Ratio
ESTA beat 18 of 32 last estimates.
56%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$66.83M
/-$0.27
Implied change from Q1 26 (Revenue/ EPS)
+11.61%
/-32.50%
Implied change from Q2 25 (Revenue/ EPS)
+30.27%
/-51.79%
Establishment Labs Holdings Inc. earnings per share and revenue
On May 06, 2026, ESTA reported earnings of -0.40 USD per share (EPS) for Q1 26, missing the estimate of -0.35 USD, resulting in a -12.80% surprise. Revenue reached 59.88 million, compared to an expected 58.64 million, with a 2.11% difference. The market reacted with a +5.00% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 9 analysts forecast an EPS of -0.27 USD, with revenue projected to reach 66.83 million USD, implying an decrease of -32.50% EPS, and increase of 11.61% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Progyny, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.30
Actual
$0.50
Surprise
+63.99%
Omada Health, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
$0.01
Surprise
+112.22%
The Oncology Institute, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.02
Surprise
+74.46%
LifeMD, Inc. Common Stock
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.20
Surprise
+12.85%
SkinHealth Systems Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.05
Surprise
+36.47%
Natera, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.54
Actual
-$0.56
Surprise
-2.36%
Viatris Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.51
Actual
$0.59
Surprise
+15.17%
Charles River Laboratories International, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$1.96
Actual
$2.06
Surprise
+4.98%
Caris Life Sciences, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
$0.00
Surprise
+100.00%
Concentra Group Holdings Parent, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.34
Actual
$0.40
Surprise
+17.03%
FAQ
What were Establishment Labs Holdings Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Establishment Labs Holdings Inc. reported EPS of -$0.40, missing estimates by -12.8%, and revenue of $59.88M, 2.11% above expectations.
How did the market react to Establishment Labs Holdings Inc.'s Q1 2026 earnings?
The stock price moved up 5%, changed from $70.99 before the earnings release to $74.54 the day after.
When is Establishment Labs Holdings Inc. expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for Establishment Labs Holdings Inc.'s next earnings report?
Based on 9
analysts, Establishment Labs Holdings Inc. is expected to report EPS of -$0.27 and revenue of $66.83M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement